您好!博飞美科试剂欢迎您! 400-608-7598

3’-氨基-2',3'-双脱氧胸苷,98%

3'-Amino-2',3'-dideoxythymidine
厂家直销
博飞美科提供的所有产品仅用于科研等非医疗用途,非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。如您需要产品COA等资料,可至下方“质量控制”中下载
PA02078
PERFEMIKER
52450-18-7
C10H15N3O4
241.24
品牌 货号 包装 纯度 目录价 会员价 库存 数量 购买车
PERFEMIKER PA02078-250mg 250mg 98% ¥505.00 登录可见优惠价格
PERFEMIKER PA02078-1g 1g 98% ¥1286.00 登录可见优惠价格
产品名称: 3’-氨基-2',3'-双脱氧胸苷,98%
中文别名: 3'-氨基-2',3'-双脱氧胸苷;3’-氨基-2'',3''-双脱氧胸苷;3’-氨基-2 ,3 -双脱氧胸苷;3’-氨基-2',3'-双脱氧胸苷;3’-氨基-2’,3’-双脱氧胸苷;3’-氨基-3’-脱氧胸苷;3''-氨基-2'',3''-双脱氧胸苷;3-氨基-2,3-双脱氧胸苷
英文名称: 3'-Amino-2',3'-dideoxythymidine
英文别名: 3'-amino-3'-deoxythymidine;3’-Amino-3’-deoxythymidine;3'-Amino-2',3'-dideoxythymidine;1-[(2R,4S,5S)-4-Amino-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione;3'-Deoxy-3'-aminothymidine;SCHEMBL1415408;DTXSID00966879;AKOS015896813;7W21M0C25B;3'-Amino-3'-deoxythymidine;BDBM50132294;1-((2R,4S,5S)-4-amino-5-(hydroxymethyl)-tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione;3'-AMINO-2',3'-DIDEOXYTHYMIDINE;1-(3-Amino-2,3-dideoxypentofuranosyl)-4-hydroxy-5-methylpyrimidin-2(1H)-one;Thymidine, 3'-amino-3'-deoxy-;CS-W012793;52450-18-7;1-((2R,4S,5S)-4-amino-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione;MFCD00038057;A829093;NI 2-110-2;CHEMBL103356;3'-Amino-3'-deoxythymidine (AMT);UNII-7W21M0C25B;ADVCGXWUUOVPPB-XLPZGREQSA-N;1-[(2R,4S,5S)-4-amino-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione;HG1142;1-[(2R,4S,5S)-4-amino-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-methyl-pyrimidine-2,4-dione;1-((2R,5S)-4-Amino-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione;Q27268932;3'-Amino-3'-deoxy-D-thymidine;1-((2R,4S,5S)-4-amino-5-(hydroxymethyl)-tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione;NSC620059;WHI-02
品牌: PERFEMIKER
CAS号: 52450-18-7
分子式: C10H15N3O4
分子量: 241.24
纯度: 98%
详细描述: 博飞美科的3’-氨基-2',3'-双脱氧胸苷,98%为核糖核苷酸及其衍生物,产品稳定,定制速度快,极大地方便了广大科研客户的使用需求。产品包装为1g。查询关键词:核糖核苷酸及其衍生物,52450-18-7,3’-氨基-2',3'-双脱氧胸苷,98%,3'-Amino-2',3'-dideoxythymidine,博飞美科,Perfemiker,上海,厂家直销。
暂无相关技术资料
暂无相关参考文献
搜索质检报告(COA)